MedTrace Logo

A 12 Week, 3-Period Study to Evaluate the Effects of a Dietary Supplement on Lipid Metabolism

NCT02366156 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2015-03-12

No results posted yet for this study

Summary

This study will evaluate the effects of encapsulated botanical extracts, previously shown to inhibit the enzyme diacylglycerol-acyltransferase-1 (DGAT-1) in vitro, on fasting and postprandial lipid metabolism during an oral fat tolerance test (OFTT) in apparently healthy, overweight and obese adult men and women.

Conditions

Interventions

DIETARY_SUPPLEMENT

Placebo

Three placebo capsules consumed prior to breakfast each day for 4 weeks

DIETARY_SUPPLEMENT

Low Dose Grape Blend

Three low dose grape blend capsules consumed prior to breakfast each day for 4 weeks.

DIETARY_SUPPLEMENT

High Dose Grape Blend

Three high dose grape blend capsules consumed prior to breakfast each day for 4 weeks.

Sponsors & Collaborators

  • Access Business Group

    lead INDUSTRY

Principal Investigators

  • Andrea Lawson, MD · Biofortis; 211 East Lake Street; Addison, IL 60101

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02366156 on ClinicalTrials.gov